Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07047937

Explainable Machine Learning for Predicting Early Gastric Cancer

Abstract Background: Early detection of gastric cancer is crucial for improving patient survival rates. Currently, the primary method for diagnosing early-stage gastric cancer is endoscopy, which has various limitations. Additionally, single laboratory tests continue to fall short of the requirements for early screening. This study aims to develop a machine learning (ML) model using clinical data to predict early-stage gastric cancer and apply SHapley Additive exPlanation (SHAP) values to explain the ML model.

Methods: This study involved patients who provided gastric tissue samples at Wenzhou Central Hospital from 2019 to 2023. The investigators gathered various laboratory test results from these patients. The investigators constructed and evaluated nine ML models to predict early-stage gastric cancer, using the area under the curve (AUC), accuracy, and sensitivity to assess their performance. For the most effective prediction model, The investigators utilized the SHAP method to determine the features' importance and explain the ML model.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Wenzhou Central Hospital

Wenzhou, Zhejiang, China

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all patients with a gastric tissue pathology result are included

Exclusion criteria

  • unclear or incomplete pathology results
  • significant missing laboratory data
  • progressive and advanced gastric cancer

Treatment and study plan

Primary outcomes

  1. Explainable machine learning for predicting early gastric cancer

    Time frame: From June 2025 to July 2025

    The area under the ROC curve (AUC) was used as the primary outcome measure

Secondary outcomes

  1. Explainable machine learning for predicting early gastric cancer

    Time frame: From June 2025 to July 2025

    We considered the sensitivity of the model as a secondary outcome measure.

Other outcomes

  1. Explainable machine learning for predicting early gastric cancer

    Time frame: From June 2025 to July 2025

    We included model accuracy as other outcome measures.

Sponsors and collaborators

Lead sponsor

Wenzhou Central Hospital

Other

Registry information

Official study title

Explainable Machine Learning for Predicting Early Gastric Cancer: a Retrospective Cohort Study

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jul 2, 2025
Registry last updated
Jul 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.